Outline for Chapters on Pathogenesis and Medical Aspects of Viruses
... employs to avoid the immune response ...
... employs to avoid the immune response ...
Management of Occupational Exposures to HBV, HCV, and HIV
... Hepatitis B vaccine series PEP should be administered as soon as possible after exposure(preferably within 24 hours). The effectiveness of HBIG when administered >7 days after is unknown. ...
... Hepatitis B vaccine series PEP should be administered as soon as possible after exposure(preferably within 24 hours). The effectiveness of HBIG when administered >7 days after is unknown. ...
Unit: Universal Precautions
... Blood, saliva and other body fluids spread virus to sexual partners, unborn infants, family members • Can survive at room temperature for at least a week • May severely damage liver, leading to cirrhosis and death (1-10%) • Greater risk of liver cancer ...
... Blood, saliva and other body fluids spread virus to sexual partners, unborn infants, family members • Can survive at room temperature for at least a week • May severely damage liver, leading to cirrhosis and death (1-10%) • Greater risk of liver cancer ...
PEGASYS (peginterferon alfa-2b)
... Pegasys alone or in combination with ribavirin without additional hepatitis antiviral drugs is not recommended for treatment of patients with chronic hepatitis C who previously failed therapy with an interferon-alfa (1). Pegasys is not recommended for treatment of patients with chronic hepatitis C w ...
... Pegasys alone or in combination with ribavirin without additional hepatitis antiviral drugs is not recommended for treatment of patients with chronic hepatitis C who previously failed therapy with an interferon-alfa (1). Pegasys is not recommended for treatment of patients with chronic hepatitis C w ...
Bacterial and Viral Infection T Chart
... BI10. d. Students know there are important differences between bacteria and viruses with respect to their requirements for growth and replication, the body’s primary defenses against bacterial and viral infections, and effective treatments of these infections. Learning Objective (s): SWBAT… Unders ...
... BI10. d. Students know there are important differences between bacteria and viruses with respect to their requirements for growth and replication, the body’s primary defenses against bacterial and viral infections, and effective treatments of these infections. Learning Objective (s): SWBAT… Unders ...
Adult Medical Surgical Nursing 1
... Hepatitis A: (HAV) RNA virus; spread by faecal-oral route (contaminated food, water, hands) Short incubation (average 30 days) Diagnosed by anti-HAV IgM in serum during an acute attack Anti-HAV IgG in serum indicates previous infection or vaccination = now immune Prevention: active immuni ...
... Hepatitis A: (HAV) RNA virus; spread by faecal-oral route (contaminated food, water, hands) Short incubation (average 30 days) Diagnosed by anti-HAV IgM in serum during an acute attack Anti-HAV IgG in serum indicates previous infection or vaccination = now immune Prevention: active immuni ...
URGENT COMMUNICATION ON THE RISK OF - ics
... Among workers in contact with monkeys or pigs infected with Reston ebolavirus, several infections have been documented in people who were clinically asymptomatic. Thus, RESTV appears less capable of causing disease in humans than other Ebola species. However, the only available evidence available c ...
... Among workers in contact with monkeys or pigs infected with Reston ebolavirus, several infections have been documented in people who were clinically asymptomatic. Thus, RESTV appears less capable of causing disease in humans than other Ebola species. However, the only available evidence available c ...
Nursing Fundamentals Name_______________________ 3.01
... Disease causing microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV) ...
... Disease causing microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV) ...
Hepatitis B Form
... _____ Yes, I already received the hepatitis B vaccine. I understand that it is my responsibility to forward a copy of my medical records as proof I have received the vaccine. ______ No, I have not received the Hepatitis B vaccine. . I understand that due to my occupational exposure to blood or other ...
... _____ Yes, I already received the hepatitis B vaccine. I understand that it is my responsibility to forward a copy of my medical records as proof I have received the vaccine. ______ No, I have not received the Hepatitis B vaccine. . I understand that due to my occupational exposure to blood or other ...
Slide 1
... Mediterranean, Africa, southeast Asia, and Oceania) the frequency of HBsAg carriers is very high. In these regions most of the inhabitants will eventually become infected with HBV and respond in one of the several ways already described. ...
... Mediterranean, Africa, southeast Asia, and Oceania) the frequency of HBsAg carriers is very high. In these regions most of the inhabitants will eventually become infected with HBV and respond in one of the several ways already described. ...
What is a virus
... What is a capsid and what does it do? A capsid is a virus’s outer protein coat. The proteins in the capsid “trick” a cell into allowing the virus inside. What are some diseases caused by viruses? Polio, measles, mumps, influenza, yellow fever, rabies and the common cold. How can someone protect them ...
... What is a capsid and what does it do? A capsid is a virus’s outer protein coat. The proteins in the capsid “trick” a cell into allowing the virus inside. What are some diseases caused by viruses? Polio, measles, mumps, influenza, yellow fever, rabies and the common cold. How can someone protect them ...
Bloodborne Pathogens
... that combines with a host cell. Retrovirus enters a host cell and changes its RNA to pro-viral ...
... that combines with a host cell. Retrovirus enters a host cell and changes its RNA to pro-viral ...
HepB Declination
... Hepatitis B virus (HBV) is an important cause of viral hepatitis. Its most important method of transmission is from the blood of acutely or chronically infected people. Health care workers are at increased risk of HBV infection because of contact with blood products. The serious complications and re ...
... Hepatitis B virus (HBV) is an important cause of viral hepatitis. Its most important method of transmission is from the blood of acutely or chronically infected people. Health care workers are at increased risk of HBV infection because of contact with blood products. The serious complications and re ...
Bloodborne Pathogens/TB
... In 2005 AIDS claimed 2.4-3.3 million lives of which, more than 570,000 were children. It is one of the most destructive pandemics in recorded history. ...
... In 2005 AIDS claimed 2.4-3.3 million lives of which, more than 570,000 were children. It is one of the most destructive pandemics in recorded history. ...
Virus
... It lack the ability of replication due to a functional disorder in some Viral genes through the replication of the slandered viruses ...
... It lack the ability of replication due to a functional disorder in some Viral genes through the replication of the slandered viruses ...
Terms you should know: parasite trophozoite cyst amoeba hepatitis
... Description: Small, naked virus with single-stranded RNA genome Diseases: Hepatitis A (symptoms appear in about 25 days); usually no complications Treatment: None; vaccine approved in 1995, recommended for travel to risk areas Reservoir and spread: Human virus; fecal-oral spread Hepatitis B virus (H ...
... Description: Small, naked virus with single-stranded RNA genome Diseases: Hepatitis A (symptoms appear in about 25 days); usually no complications Treatment: None; vaccine approved in 1995, recommended for travel to risk areas Reservoir and spread: Human virus; fecal-oral spread Hepatitis B virus (H ...
Immunology Stack
... 2. A low level of virus production occurs within ganglion cells and is release in a burst from the axon. These then replicate in the epithelium. (store and release) ...
... 2. A low level of virus production occurs within ganglion cells and is release in a burst from the axon. These then replicate in the epithelium. (store and release) ...
Glossary
... immune globulin injections to children and staff in a child care setting when cases of hepatitis A occur immunity: The body’s ability to fight a particular infection. For example, a child acquires immunity to disease such as measles, mumps, rubella and pertussis after natural infection or by immuniz ...
... immune globulin injections to children and staff in a child care setting when cases of hepatitis A occur immunity: The body’s ability to fight a particular infection. For example, a child acquires immunity to disease such as measles, mumps, rubella and pertussis after natural infection or by immuniz ...
Western Carolina University Hepatitis B Vaccination Declination Form
... INSTRUCTIONS: Every employee covered by the OSHA Bloodborne Pathogens Standard must complete EITHER this form OR the Hepatitis B Vaccination Consent Form. ...
... INSTRUCTIONS: Every employee covered by the OSHA Bloodborne Pathogens Standard must complete EITHER this form OR the Hepatitis B Vaccination Consent Form. ...
File
... A nonliving strand of genetic material within a protein coat No organelles to take in nutrients or use energy Cannot make proteins Cannot move Cannot replicate on their own Most viruses range in size from 5 to 300 nanometers. Virus Origin Viruses came from parts of cells. Genetic mat ...
... A nonliving strand of genetic material within a protein coat No organelles to take in nutrients or use energy Cannot make proteins Cannot move Cannot replicate on their own Most viruses range in size from 5 to 300 nanometers. Virus Origin Viruses came from parts of cells. Genetic mat ...
Hepatitis A and B information sheet
... The virus is carried in all body fluids: blood, saliva, semen and vaginal secretions, breast milk, tears and perspiration. It is usually picked up by absorption of infectious blood through cuts and sores in the skin, by sexual intercourse or by sharing infected items such as razor blades, toothbrush ...
... The virus is carried in all body fluids: blood, saliva, semen and vaginal secretions, breast milk, tears and perspiration. It is usually picked up by absorption of infectious blood through cuts and sores in the skin, by sexual intercourse or by sharing infected items such as razor blades, toothbrush ...
Appendix B University of Delaware Hepatitis B Vaccination Declination Form
... The dates of vaccination, to the best of my knowledge, are: Vaccine 1: ________________ Vaccine 2: ________________ Vaccine 3: ________________ Please attach a copy of any vaccination verification if possible. ...
... The dates of vaccination, to the best of my knowledge, are: Vaccine 1: ________________ Vaccine 2: ________________ Vaccine 3: ________________ Please attach a copy of any vaccination verification if possible. ...
(HBsAg) REFLEX
... interpreted in conjunction with test results of other HBV serologic markers (e.g., anti-HBs antibody, anti-HBc total antibody, anti-HBc IgM antibody). Not suitable as a stand-alone prenatal screening test of HbsAg status in pregnant women. Positive HbsAg test results should be reported by the health ...
... interpreted in conjunction with test results of other HBV serologic markers (e.g., anti-HBs antibody, anti-HBc total antibody, anti-HBc IgM antibody). Not suitable as a stand-alone prenatal screening test of HbsAg status in pregnant women. Positive HbsAg test results should be reported by the health ...
Hepatitis B
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both acute and chronic infections. Many people have no symptoms during the initial infection. Some develop a rapid onset of sickness with vomiting, yellowish skin, feeling tired, dark urine and abdominal pain. Often these symptoms last a few weeks and rarely does the initial infection result in death. It may take 30 to 180 days for symptoms to begin. In those who get infected around the time of birth 90% develop chronic hepatitis B while less than 10% of those infected after the age of five do. Most of those with chronic disease have no symptoms; however, cirrhosis and liver cancer may eventually develop. These complications results in the death of 15 to 25% of those with chronic disease.The virus is transmitted by exposure to infectious blood or body fluids. Infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person, travel in countries where the infection rate is high, and living in an institution. Tattooing and acupuncture led to a significant number of cases in the 1980s; however, this has become less common with improved sterility. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The infection can be diagnosed 30 to 60 days after exposure. Diagnosis is typically by testing the blood for parts of the virus and for antibodies against the virus. It is one of five known hepatitis viruses: A, B, C, D, and E.The infection has been preventable by vaccination since 1982. Vaccination is recommended by the World Health Organization in the first day of life if possible. Two or three more doses are required at a later time for full effect. This vaccine works about 95% of the time. About 180 countries gave the vaccine as part of national programs as of 2006. It is also recommended that all blood be tested for hepatitis B before transfusion and condoms be used to prevent infection. During an initial infection, care is based on the symptoms that a person has. In those who develop chronic disease antiviral medication such as tenofovir or interferon maybe useful, however these drugs are expensive. Liver transplantation is sometimes used for cirrhosis.About a third of the world population has been infected at one point in their lives, including 240 million to 350 million who have chronic infections. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults have chronic disease. Rates in Europe and North America are less than 1%. It was originally known as serum hepatitis. Research is looking to create foods that contain HBV vaccine. The disease may affect other great apes as well.